4/A//SEC Filing
Dalgleish Scott 4/A
Accession 0001628280-22-007760
CIK 0001799191other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 8:10 PM ET
Size
6.0 KB
Accession
0001628280-22-007760
Insider Transaction Report
Form 4/AAmended
Dalgleish Scott
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2022-03-21+162,891→ 162,891 totalExercise: $7.09Exp: 2032-03-21→ Common stock (162,891 underlying)
Footnotes (1)
- [F1]The stock options vest as to 1/3rd of the options granted on the second anniversary of November 12, 2021 (the "Vesting Commencement Date"), with the remaining options vesting in four equal annual installments beginning on the third anniversary of the Vesting Commencement Date, with all options becoming vested on the sixth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
Documents
Issuer
Oncology Institute, Inc.
CIK 0001799191
Entity typeother
Related Parties
1- filerCIK 0001891053
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 8:10 PM ET
- Size
- 6.0 KB